- Home
- ANL vs VATE Comparison
ANL vs VATE Comparison
Compare ANL & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANL | VATE |
|---|---|---|
| Founded | 2004 | 1994 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Metal Fabrications |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 70.3M |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ANL | VATE |
|---|---|---|
| Price | $1.64 | $4.50 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.5K | 16.3K |
| Earning Date | 04-20-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,099,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $4.05 |
| 52 Week High | $2.99 | $13.79 |
Technical Indicators
Market Signals| Indicator | ANL | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 61.06 | 37.82 |
| Support Level | $0.88 | $4.16 |
| Resistance Level | $1.59 | $5.28 |
| Average True Range (ATR) | 0.18 | 0.25 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 92.82 | 30.35 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.